No results found for “”
No results found for filter “”
-
Blog articles 09.08.19
For the chance to eat sun-warmed strawberries from my own garden (Guest blog)
I know that much of these conditions is down to genetics and in my ideal future, science and medicine will have advanced so that my children and grandchildren...
Read Article -
EFPIA News 25.07.19
Unleashing the potential of data to improve cancer care
Report from the Oncology Data Summit
Read Article -
EFPIA News 25.07.19
A busy year, before a hectic autumn
Our Oncology Platform has tackled several topics from big data and AI to drug pricing and improving patient outcomes.
Read Article -
Blog articles 22.07.19
I won't rest until we further improve the life of patients with artery disease (Guest blog)
A guest blog by Stefan Heitmeier, Principle Scientist, Cardiovascular Research at Bayer
Read Article -
Blog articles 18.07.19
Connecting the European cancer community with data in new and powerful ways (Guest blog)
The pace of innovation in cancer treatment offers tremendous potential for patients. 2018 saw the highest number of oncology therapeutics launched per...
Read Article -
Blog articles 11.07.19
People & patents: the key to investing in innovation (Guest blog)
All of today’s life-changing medicines began as a bright idea – perhaps in the minds of university scientists or entrepreneurs launching a start-up. Translating...
Read Article -
Statements & press releases 09.07.19
EFPIA, EATRIS, ELIXIR, BBMRI, ECRIN statement on the role of research infrastructures to boost patient-centred...
Academia and research-intensive health industries need a vibrant, world-class, inter-connected health and research ecosystem to effectively translate ideas...
Read Article -
Blog articles 09.07.19
An ageing population – the good, the bad and the silver lining
Our biggest challenge could be Europe’s biggest opportunity. Let’s take it!
Read Article -
Statements & press releases 02.07.19
Value-based healthcare – an EFPIA perspective
How should the "value" in value-based healthcare be defined, how can a value-based approach help European health systems become more effective, accessible...
Read Article -
Statements & press releases 01.07.19
EFPIA response to the EMA Regulatory Science Strategy to 2025
EFPIA has identified a series of priorities that the innovative biopharmaceutical industry believes will have the most substantive benefit for European...
Read Article -
Statements & press releases 27.06.19
New Report underlines the critical strategic importance of the research-based pharmaceutical industry...
Today, EFPIA published a report by PwC on the economic and social footprint of the pharmaceutical industry in Europe
Read Article -
Statements & press releases 27.06.19
New EFPIA leadership targets a collaborative approach to address Europe’s health challenges
At today’s EFPIA General Assembly in Brussels, Jean-Christophe Tellier, CEO and Chairman of the Executive Committee of UCB was elected as EFPIA President...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 25.07.19
Unleashing the potential of data to improve cancer care
Report from the Oncology Data Summit
Read Article -
EFPIA News 25.07.19
A busy year, before a hectic autumn
Our Oncology Platform has tackled several topics from big data and AI to drug pricing and improving patient outcomes.
Read Article -
EFPIA News 06.02.19
Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver
For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in future. We are deeply concerned that...
Read Article -
EFPIA News 26.09.18
The Value of Health: Improving Outcomes
More effective, patient-centred, and sustainable health systems: the benefits of health outcomes measurement
Read Article -
EFPIA News 07.08.18
Exploring the science and innovation behind #WeWontRest
A new partnership with ITN Productions
Read Article -
EFPIA News 26.06.18
Video and report of the Unlocking Tomorrow’s Cures Exhibition, 22-25 May 2018, European Parliament
The exhibition explored the cutting-edge science behind new treatments and how it is transforming patients’ lives.
Read Article -
EFPIA News 25.06.18
Apply now for the Health Collaboration Awards 2018
Submit a project by 21 September 2018
Read Article -
EFPIA News 08.05.18
EFPIA position on proposal for a Regulation of the European Parliament and the Council on HTA and amending...
This paper outlines EFPIA’s views on the four pillars of EU HTA cooperation included in the Commission proposal
Read Article -
EFPIA News 03.05.18
Early Career Research Prize in Vaccinology R&D – 2nd edition
Promote and foster a younger generation of scientists in the early stages of their career!
Read Article -
EFPIA News 03.07.17
EFPIA-College of Europe Prize
The 2017 Laureat of the EFPIA-College of Europe Prize is Luca Deplano
Read Article -
EFPIA News 30.05.17
Final Call ATMP Survey
Help improve product development and regulation
Read Article -
EFPIA News 24.04.17
Open Letter from the Pharmaceutical Industry Heads of Research and EFPIA on the Relocation of the European...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 09.07.19
EFPIA, EATRIS, ELIXIR, BBMRI, ECRIN statement on the role of research infrastructures to boost patient-centred...
Academia and research-intensive health industries need a vibrant, world-class, inter-connected health and research ecosystem to effectively translate ideas...
Read Article -
Statements & press releases 02.07.19
Value-based healthcare – an EFPIA perspective
How should the "value" in value-based healthcare be defined, how can a value-based approach help European health systems become more effective, accessible...
Read Article -
Statements & press releases 01.07.19
EFPIA response to the EMA Regulatory Science Strategy to 2025
EFPIA has identified a series of priorities that the innovative biopharmaceutical industry believes will have the most substantive benefit for European...
Read Article -
Statements & press releases 27.06.19
New Report underlines the critical strategic importance of the research-based pharmaceutical industry...
Today, EFPIA published a report by PwC on the economic and social footprint of the pharmaceutical industry in Europe
Read Article -
Statements & press releases 27.06.19
New EFPIA leadership targets a collaborative approach to address Europe’s health challenges
At today’s EFPIA General Assembly in Brussels, Jean-Christophe Tellier, CEO and Chairman of the Executive Committee of UCB was elected as EFPIA President...
Read Article -
Statements & press releases 20.06.19
Working together for patients
Pharmaceutical companies continue to drive transparency and underline industry investment in Europe’s healthcare
Read Article -
Statements & press releases 19.06.19
EU Health Coalition calls upon the European Council to increase the total Horizon Europe budget to €120...
Ahead of the European Council Meeting (20-21 June), the EU Health Coalition calls upon Member States to adopt a Multiannual Financial Framework as well...
Read Article -
Statements & press releases 11.06.19
Road to Value Based Healthcare
A full-day seminar in Warsaw on the role of outcomes-measurement in delivering more for patients and improving the long-term sustainability of our health...
Read Article -
Statements & press releases 23.05.19
From votes to vision
The health of the EU’s citizens depends on all of us - policy-makers, healthcare professionals, civil society and industry. Pooling our resources and expertise...
Read Article -
Statements & press releases 08.05.19
EFPIA and CPIA Joint China/EU Pharmaceutical Industry Forum to Explore New Frontiers in Pharmaceutical...
The workshop covers 4 different themes: Pharmaceuticals in the Environment, Pricing & Reimbursement, Compliance (marketing ethics) and NMPA in the ICH
Read Article -
Statements & press releases 17.04.19
Health industries welcome unprecedented progress leading to an adoption of Horizon Europe, its areas...
The text agreed allows our sectors to remain ambitious about a healthier future for European citizens, based on medical innovation, timely access to quality...
Read Article -
Statements & press releases 17.04.19
Redressing Europe’s innovation balance
As the waiver will hit innovation in Europe, the research-based industry stands ready to work with policy makers across Europe to see how we can restore...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 09.08.19
For the chance to eat sun-warmed strawberries from my own garden (Guest blog)
I know that much of these conditions is down to genetics and in my ideal future, science and medicine will have advanced so that my children and grandchildren...
Read Article -
Blog articles 22.07.19
I won't rest until we further improve the life of patients with artery disease (Guest blog)
A guest blog by Stefan Heitmeier, Principle Scientist, Cardiovascular Research at Bayer
Read Article -
Blog articles 18.07.19
Connecting the European cancer community with data in new and powerful ways (Guest blog)
The pace of innovation in cancer treatment offers tremendous potential for patients. 2018 saw the highest number of oncology therapeutics launched per...
Read Article -
Blog articles 11.07.19
People & patents: the key to investing in innovation (Guest blog)
All of today’s life-changing medicines began as a bright idea – perhaps in the minds of university scientists or entrepreneurs launching a start-up. Translating...
Read Article -
Blog articles 09.07.19
An ageing population – the good, the bad and the silver lining
Our biggest challenge could be Europe’s biggest opportunity. Let’s take it!
Read Article -
Blog articles 26.06.19
#WeWontRest until people with rare diseases get faster access to medicines, based on innovative access...
A guest blog by Rute Fernandes, Group President and Head of Rare Diseases for Europe and Canada at Takeda
Read Article -
Blog articles 20.06.19
European Healthcare: So much we can build on, so much left to do
From immuno-oncology to gene and cell therapy, we are seeing new medicines that give hope to patients who until recently have had no treatment options
Read Article -
Blog articles 20.06.19
The story behind the numbers
This week EFPIA produced its annual statistics report. What is the story behind the numbers? What are we seeing as the key trends and, as a new EU mandate...
Read Article -
Blog articles 17.06.19
New study on sustainability of the European off-patent biologics market
A new study by the Pugatch Consilium, commissioned by EFPIA, shows that many European countries are focusing on maximising short-term savings rather than...
Read Article -
Blog articles 17.06.19
Harnessing Real-World Data: Are We There Yet? (Guest blog)
For the most part, today’s health data landscape is still lingering in the 20th century. It consists largely of a myriad of languages, systems and structures,...
Read Article -
Blog articles 14.06.19
Rare & childhood diseases: addressing unmet need
With the right framework in place we can continue to work together to meet the needs of children and adults living with a rare disease. As an industry...
Read Article -
Blog articles 13.06.19
Can registries drive better outcomes for diabetes patients? (Guest blog)
A roundtable in Stockholm will explore the opportunities and barriers to diabetes registries
Read Article